article thumbnail

Does the Drug Shortage White Paper Fall Short?

FDA Law Blog: Biosimilars

Department of Health and Human Services (HHS) recently published a White Paper on Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States —with input from several HHS stakeholders, including FDA, CMS, and the Administration for Strategic Preparedness and Response. By Kalie E.

Drugs 59
article thumbnail

White Paper: Read the Top Five Benefits of a Cloud ELN

Drug Discovery World

Read the white paper brought to you by PerkinElmer Informatics to learn: The top five factors of a cloud ELN that meet, or exceed, the needs of R&D scientists and satisfy the IT department too. The post White Paper: Read the Top Five Benefits of a Cloud ELN appeared first on Drug Discovery World (DDW).

Drugs 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Analysis Chemical: EPA releases white paper for second part of the risk evaluation for asbestos

Agency IQ

EPA releases white paper for second part of the risk evaluation for asbestos The Environmental Protection Agency has published a white paper on the quantitative human health approach to inform the Risk Evaluation for Asbestos, Part 2.

40
article thumbnail

Analysis Chemical Thank You EPA releases white paper for second part of the risk evaluation for asbestos

Agency IQ

EPA releases white paper for second part of the risk evaluation for asbestos The Environmental Protection Agency has published a white paper on the quantitative human health approach to inform the Risk Evaluation for Asbestos, Part 2. Small manufacturers, importers, and processors are not included in this requirement.

article thumbnail

Analysis Chemical Thank You EPA issues white paper exploring the adoption of structured content and digital pesticide labels

Agency IQ

EPA issues white paper exploring the adoption of structured content and digital pesticide labels FDA delays enforcement of cosmetic product listing and facility registration, issues finalized guidance The EPA’s Office of Pesticide Programs (OPP) is in the developmental stage of creating a structured pesticide and digital pesticide label.

article thumbnail

EPA issues white paper exploring the adoption of structured content and digital pesticide labels

Agency IQ

The EPA’s Office of Pesticide Programs (OPP) is in the developmental stage of creating a structured pesticide and digital pesticide label. Both labels would provide the framework for the consistent placement and order of the regulated portions of pesticide label information, with the digital label organizing the contents as data.

article thumbnail

Your Guide to the Ultimate Pharmaceutical Product Improvement Tool

Fierce BioTech

Your Guide to the Ultimate Pharmaceutical Product Improvement Tool This white paper will review how automating the annual product quality review (APQR) process can help pharmaceutical companies simplify and optimize their product quality review process, to make informed product quality decisions quicker and on a more routine and proactive basis.